The role of individual factors in behavioral neuroscience is an important, but still neglected, area of research. For example, the Elevated Plus-Maze Test has been one of the most used paradigms to gauge unconditioned aversively motivated behavior in rodents. However, despite a great number of experiments with this test there have been only few efforts to assess systematic individual variations in the elevated plus-maze and related neurobiological functions. The present review aims to give, first, a general overview and introduction about the test, and second, an animal model of anxiety based on natural variance of plus-maze behavior within a given unselected population of rats. Finally, critical aspects of such approaches in animal research are discussed, and suggestions are given as to where to go from here.
AbramsonL. Y.SeligmanM. E. P. (1977). Modeling psychopathology in the laboratory: History and rationale. In MaserJ. D.SeligmanM. E. P. (Eds.), Psychopathology: Experimental models (pp. 1–26). San Francisco, CA: Freeman.
2.
AlmeidaS. S.GarciaR. A.de OliveiraL. M. (1993). Effects of early protein malnutrition and repeated testing upon locomotor and exploratory behaviors in the elevated plus-maze. Physiology & Behavior, 54, 749–752.
3.
AlmeidaS. S.TonkissJ.GallerJ. R. (1996). Prenatal protein malnutrition affects exploratory behavior of female rats in the elevated plus-maze test. Physiology & Behavior, 60, 675–680.
4.
AmelangM.BartussekD.StemmlerG.HagemannD. (2006). Differentielle Psychologie und Persönlichkeitsforschung [Differential psychology and personality research] (6th ed.). Stuttgart, Germany: Kohlhammer.
5.
AndradeM. M. M.ToméM. F.SantiagoE. S.Lúcia-SantosA.de AndradeT. G. C. S. (2003). Longitudinal study of daily variation of rats’ behavior in the elevated plus-maze. Physiology & Behavior, 78, 125–133.
6.
AndreatiniR.BlanchardC.BlanchardR.BrandãoM. L.CarobrezA. P.GriebelG.… GraeffF. G. (2001). The brain decade in debate: II. Panic or anxiety? From animal models to a neurobiological basis. Brazilian Journal of Medical and Biological Research, 34, 145–154.
7.
AndreatiniR.VitalM. A. B. F.SantosG. L. (2003). The reinstatement of conflict reverses the one-trial tolerance to diazepam on elevated plus-maze. European Neuropsychopharmacology, 13, Suppl. 4, 378–379.
8.
AndrewsN.FileS. E. (1993). Handling history of rats modifies behavioural effects of drugs in the elevated plus-maze test of anxiety. European Journal of Pharmacology, 235, 109–112.
9.
BarlowD. H. (2002). Anxiety and its disorders: The nature and treatment of anxiety and panic (2nd ed.). New York, NY: Guilford Press.
10.
BauhoferA.SchwartingR. K. W.KösterM.SchmittA.LorenzW.PawlakC. R. (2004). Sickness behavior of rats with abdominal sepsis can be improved by antibiotic and G-CSF prophylaxis in clinic modeling randomized trials. Inflammation Research, 53, 697–705.
11.
BinderE.DrosteS. K.OhlF.ReulJ. M. H. M. (2004). Regular voluntary exercise reduces anxiety-related behaviour and impulsiveness in mice. Behavioural Brain Research, 155, 197–206.
12.
BlanchardD. C.BlanchardR. J. (1988). Ethoexperimental approaches to the biology of emotion. Annual Review of Psychology, 39, 43–68.
13.
BlanchardR. J.BlanchardD. C. (1989). Antipredator defensive behaviors in a visible burrow system. Journal of Comparative Psychology, 103, 70–82.
14.
BlanchardR. J.BlanchardD. C. (1990). An ethoexperimental analysis of defense, fear and anxiety. In McNaughtonN.AndrewsG. (Eds.), Anxiety (pp. 124–133). Dunedin, New Zealand: Otago University Press.
15.
BlanchardR. J.ParmigianiS.BjornsonC.MasudaC.WeissS. M.BlanchardD. C. (1995). Antipredator behaviour of Swiss-Webster mice in a visible burrow system. Aggressive Behavior, 21, 123–136.
16.
BlanchardR. J.YudkoE. B.RodgersR. J.BlanchardD. C. (1993). Defense system psychopharmacology: An ethological approach to the pharmacology of fear and anxiety. Behavioural Brain Research, 58, 155–165.
17.
BoissierJ. R. (Ed.). (1978). Differential psychopharmacology on anxiolytics and sedatives. Modern Trends in Pharmacopsychiatry, 14, 143–156. Karger: Basel.
18.
BorsiniF.PodhornaJ.MarazzitiD. (2002). Do animal models of anxiety predict anxiolytic-like effects of antidepressants?Psychopharmacology, 163, 121–141.
19.
BortaA.SchwartingR. K. W. (2005a). Inhibitory avoidance, pain reactivity, and plus-maze behaviour in Wistar rats with high versus low rearing activity. Physiology & Behavior, 84, 387–396.
20.
BortaA.SchwartingR. K. W. (2005b). Post-trial treatment with the nicotinic agonist metanicotine: Differential effects in Wistar rats with high versus low rearing activity. Pharmacology, Biochemistry and Behavior, 80, 541–548.
21.
BortaA.WöhrM.SchwartingR. K. W. (2006). Rat ultrasonic vocalization in aversively motivated situations and the role of individual differences in anxiety-related behavior. Behavioural Brain Research, 166, 271–280.
22.
BouchardT. J.Jr. (1994). Genes, environment, and personality. Science, 264, 1700–1701.
23.
BrioniJ. D.OrsingherO. A. (1988). Operant behavior and reactivity to the anticonflict effect of diazepam in perinatally undernourished rats. Physiology & Behavior, 44, 193–198.
CalderA. J.LawrenceA. D.YoungA. W. (2001). Neuropsychology of fear and loathing. Nature Reviews Neuroscience, 2, 352–363.
26.
Canto-de-SouzaA.Nunes-de-SouzaR. L.RodgersR. J. (2002). Anxiolytic-like effect of way-100635 microinfusions into the median (but not dorsal) raphe nucleus in mice exposed to the plus-maze: Influence of prior test experience. Brain Research, 928, 50–59.
27.
CapitanioJ. P. (1985). Early experience and social processes in rhesus macaques (Macaca mulatta): II. Complex social interaction. Journal of Comparative Psychology, 99, 133–144.
28.
CarobrezA. P.BertoglioL. J. (2005). Ethological and temporal analyses of anxiety-like behavior: The elevated plus-maze model 20 years on. Neuroscience & Biobehavioral Reviews, 29, 1193–1205.
29.
CarverC. S. (2005). Impulse and constraint: Perspectives from personality psychology, convergence with theory in other areas, and potential for integration. Personality and Social Psychology Review, 9, 312–333.
30.
ClémentY.CalatayudF.BelzungC. (2002). Genetic basis of anxiety-like behaviour: A critical review. Brain Research Bulletin, 57, 57–71.
31.
CloningerC. R.SvrakicD. M.PrzybeckT. R. (1993). A psychobiological model of temperament and character. Archives of General Psychiatry, 50, 975–990.
32.
CrabbeJ. C.WahlstenD.DudekB. C. (1999). Genetics of mouse behavior: Interactions with laboratory environment. Science, 284, 1670–1672.
33.
Cruz-MoralesS. E.SantosN. R.BrandãoM. L. (2002). One-trial tolerance to midazolam is due to enhancement of fear and reduction of anxiolytic-sensitive behaviors in the elevated plus-maze retest in the rat. Pharmacology, Biochemistry and Behavior, 72, 973–978.
34.
DantzerR.O’ConnorJ. C.FreundG. G.JohnsonR. W.KelleyK. W. (2008). From inflammation to sickness and depression: When the immune system subjugates the brain. Nature Reviews Neuroscience, 9, 46–57.
35.
DavisM.WalkerD.LeeY. (1997). Roles of the amygdala and bed nucleus of the stria terminalis in fear and anxiety measured with the acoustic startle reflex. Possible relevance to PTSD. Annals of the New York Academy of Sciences, 821, 305–331.
36.
DeakinJ. F. W.GraeffF. G. (1991). 5-HT and mechanisms of defence. Journal of Psychopharmacology, 5, 305–315.
37.
DepueR.LenzenwegerM. (2005). A neurobehavioral dimensional model of personality disturbance. In LenzenwegerM.ClarkinJ. (Eds.), Theories of personality disorders (2nd ed.) (pp. 136–176). New York, NY: Guilford Press.
38.
DereE.De Souza-SilvaM. A.FrischC.TeubnerB.SöhlG.WilleckeK.HustonJ. P. (2003). Connexin30-deficient mice show increased emotionality and decreased rearing activity in the open-field along with neurochemical changes. European Journal of Neuroscience, 18, 629–638.
39.
EnkelT.GholizadehD.von Bohlen und HalbachO.Sanchis-SeguraC.HurlemannR.SpanagelR.… VollmayrB. (2010). Ambiguous-cue interpretation is biased under stress- and depression-like states in rats. Neuropsychopharmacology, 35, 1008–1015.
40.
FedotovaJ. O.HartmannG.LénárdL.SapronovN. S. (2004). Effects of 5-HT1A receptor agonist and antagonist on anxiety in intact and ovariectomized female rats. Acta Physiologica Hungarica, 91, 175–184.
41.
FernandesC.FileS. E. (1996). The influence of open arm ledges and maze experience in the elevated plus-maze. Pharmacology, Biochemistry and Behavior, 54, 31–40.
42.
Fernández-TeruelA.EscorihuelaR. M.GrayJ. A.AguilarR.GilL.Giménez-LlortL.… FlintJ. (2002). A quantitative trait locus influencing anxiety in the laboratory rat. Genome Research, 12, 618–626.
43.
FerreiraT. L.MoreiraK. M.IkedaD. C.BuenoO. F. A.OliveiraM. G. M. (2003). Effects of dorsal striatum lesions in tone fear conditioning and contextual fear conditioning. Brain Research, 987, 17–24.
44.
FileS. E. (1990). One-trial tolerance to the anxiolytic effects of chlordiazepoxide in the plus-maze. Psychopharmacology, 100, 281–282.
45.
FileS. E. (2001). Factors controlling measures of anxiety and responses to novelty in the mouse. Behavioural Brain Research, 125, 151–157.
46.
FileS. E.AndrewsN.WuP. Y.ZharkovskyA.ZangrossiH.Jr. (1992). Modification of chlordiazepoxide’s behavioural and neurochemical effects by handling and plus-maze experience. European Journal of Pharmacology, 218, 9–14.
47.
FileS. E.GonzalezL. E.GallantR. (1998). Role of the basolateral nucleus of the amygdala in the formation of a phobia. Neuropsychopharmacology, 19, 397–405.
48.
FileS. E.KennyP. J.CheetaS. (2000). The role of the dorsal hippocampal serotonergic and cholinergic systems in the modulation of anxiety. Pharmacology Biochemistry and Behavior, 66, 65–72.
49.
FileS. E.MabbuttP. S.HitchcottP. (1990). Characterisation of the phenomenon of “one-trial tolerance” to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze. Psychopharmacology, 102, 98–101.
50.
FileS. E.ZangrossiH.Jr. (1993). “One-trial tolerance” to the anxiolytic actions of benzodiazepines in the elevated plus-maze, or the development of a phobic state?Psychopharmacology, 110, 240–244.
51.
FileS. E.ZangrossiH.Jr.VianaM.GraeffF. G. (1993). Trial 2 in the elevated plus-maze: A different form of fear?Psychopharmacology, 111, 491–494.
52.
FinnD. A.Rutledge-GormanM. T.CrabbeJ. C. (2003). Genetic animal models of anxiety. Neurogenetics, 4, 109–135.
53.
FlintJ. (2003). Analysis of quantitative trait loci that influence animal behavior. Journal of Neurobiology, 54, 46–77.
54.
FrancisR. C. (1990). Temperament in a fish: A longitudinal study of the development of individual differences in aggression and social rank in the Midas cichlid. Ethology, 86, 311–325.
55.
Frussa-FilhoR.de RibeiroR. A. (2002). One-trial tolerance to the effects of chlordiazepoxide in the elevated plus-maze is not due to acquisition of a phobic avoidance of open arms during initial exposure. Life Sciences, 71, 519–525.
56.
GarbeC. M.KembleE. D. (1994). Effects of prior agonistic experience on risk assessment and approach behavior evoked by familiar and unfamiliar conspecific odors. Aggressive Behavior, 20, 143–149.
57.
GarciaA. M. B.CardenasF. P.MoratoS. (2005). Effect of different illumination levels on rat behavior in the elevated plus-maze. Physiology & Behavior, 85, 265–270.
58.
GonzalezL. E.FileS. E. (1997). A five minute experience in the elevated plus-maze alters the state of benzodiazepine receptor in the dorsal raphe nucleus. The Journal of Neuroscience, 17, 1505–1511.
59.
GoslingS. D. (1998). Personality dimensions in spotted hyenas (Crocuta crocuta). Journal of Comparative Psychology, 112, 107–118.
60.
GoslingS. D. (2001). From mice to men: What can we learn about personality from animal research?Psychological Bulletin, 127, 45–86.
61.
GraeffF. G. (1994). Neuroanatomy and neurotransmitter regulation of defensive behaviors and related emotions in animals. Brazilian Journal of Medical and Biological Research, 27, 811–829.
62.
GraeffF. G.GuimarãesF. S.De AndradeT. G. C. S.DeakinJ. F. W. (1996). Role of 5-HT in stress, anxiety, and depression. Pharmacology, Biochemistry and Behavior, 54, 129–141.
63.
GrayJ. A. (1982). The neuropsychology of anxiety: An enquiry into the functions of the septo-hippocampal system (1st ed.). Oxford, UK: Oxford University Press.
64.
GrayJ. A.McNaughtonN. (2000). The neuropsychology of anxiety: An enquiry into the functions of the septo-hippocampal system (2nd ed.). Oxford, UK: Oxford University Press.
65.
GraybielA. M.RauchS. L. (2000). Toward a neurobiology of obsessive-compulsive disorder. Neuron, 28, 343–347.
66.
GrossC.HenR. (2004). The developmental origins of anxiety. Nature Reviews Neuroscience, 5, 545–552.
67.
HallidayT. R. (1976). The libidinous newt: An analysis of variations in the sexual behaviour of the male smooth newt, Triturus vulgaris. Animal Behaviour, 24, 398–414.
68.
HandleyS. L.McBlaneJ. W. (1993). 5-HT drugs in animal models of anxiety. Psychopharmacology, 112, 13–20.
69.
HaslerG.FrommS.AlvarezR. P.LuckenbaughD. A.DrevetsW. C.GrillonC. (2007). Cerebral blood flow in immediate and sustained anxiety. The Journal of Neuroscience, 27, 6313–6319.
70.
HasuoC. (1935). Effects of milieu upon character: I. Experiments with young chickens. Japanese Journal of Experimental Psychology, 2, 109–118.
71.
HebbD. O. (1949). Temperament in chimpanzees: I. Method and analyses. The Journal of Comparative and Physiological Psychology, 42, 192–206.
HoY. J.EichendorffJ.SchwartingR. K. W. (2002). Individual response profiles of male Wistar rats in animal models for anxiety and depression. Behavioural Brain Research, 136, 1–12.
74.
HoY. J.PawlakC. R.GuoL.SchwartingR. K. W. (2004). Acute and long-term consequences of single MDMA administration in relation to individual anxiety levels in the rat. Behavioural Brain Research, 149, 135–144.
75.
HoY. J.WangC. F.HsuW. Y.TsengT.HsuC. C.KaoM. D.TsaiY. F. (2007). Psychoimmunological effects of dioscorea in ovariectomized rats: Role of anxiety level. Annals of General Psychiatry, 6, 21, doi:10.1186/1744-859X-6-2110.1186/1744-859X-6-21
76.
HoggS. (1996). A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacology, Biochemistry and Behavior, 54, 21–30.
77.
HolmesA.RodgersR. J. (1998). Responses of Swiss-Webster mice to repeated plus-maze experience: Further evidence for a qualitative shift in emotional state?Pharmacology, Biochemistry and Behavior, 60, 473–488.
78.
HorvitzJ. C. (2000). Mesolimbocortical and nigrostriatal dopamine responses to salient non-reward events. Neuroscience, 96, 651–656.
79.
JensenJ.McIntoshA. R.CrawleyA. P.MikulisD. J.RemingtonG.KapurS. (2003) Direct activation of the ventral striatum in anticipation of aversive stimuli. Neuron, 40, 1251–1257.
80.
KabbajM.AkilH. (2001). Individual differences in novelty-seeking behavior in rats: A c-fos study. Neuroscience, 106, 535–545.
81.
KaesermannH. P. (1986). Stretched attend posture, a non-social form of ambivalence, is sensitive to a conflict-reducing drug action. Psychopharmacology, 89, 31–37.
82.
KarlT.PabstR.von HörstenS. (2003). Behavioral phenotyping of mice in pharmacological and toxicological research. Experimental and Toxicologic Pathology, 55, 69–83.
83.
KarrenbauerB. D.HoY. J.LudwigV.LöhnJ.SpanagelR.SchwartingR. K. W.PawlakC. R. (2009). Time-dependent effects of striatal interleukin-2 on open field behaviour in rats. Journal of Neuroimmunology, 208, 10–18.
84.
KhanA. A.JacobsonK. C.GardnerC. O.PrescottC. A.KendlerK. S. (2005). Personality and comorbidity of common psychiatric disorders. British Journal of Psychiatry, 186, 190–196.
85.
KitabatakeY.HikidaT.WatanabeD.PastanI.NakanishiS. (2003). Impairment of reward-related learning by cholinergic cell ablation in the striatum. Proceedings of the National Academy of Sciences, USA, 100, 7965–7970.
86.
KõksS.BeljajevS.KoovitI.AbramovU.BourinM.VasarE. (2001). 8-OH-DPAT, but not deramciclane, antagonizes the anxiogenic-like action of paroxetine in an elevated plus-maze. Psychopharmacology, 153, 365–372.
87.
LaaksoA.WalliusE.KajanderJ.BergmanJ.EskolaO.SolinO.… HietalaJ. (2003). Personality traits and striatal dopamine synthesis capacity in healthy subjects. American Journal of Psychiatry, 160, 904–910.
88.
LatheR. (2004). The individuality of mice. Genes, Brain and Behavior, 3, 317–327.
89.
LeDouxJ. E. (2000). Emotion circuits in the brain. Annual Review of Neuroscience, 23, 155–184.
90.
LetwinN. E.KafkafiN.BenjaminiY.MayoC.FrankB. C.LuuT.… ElmerG. I. (2006). Combined application of behavior genetics and microarray analysis to identify regional expression themes and gene–behaviour associations. The Journal of Neuroscience, 26, 5277–5287.
ListerR. G. (1987). The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology, 92, 180–185.
93.
LondonE. D.SimonS. L.BermanS. M.MandelkernM. A.LichtmanA. M.BramenJ.… LingW. (2004). Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers. Archives of General Psychiatry, 61, 73–84.
94.
LorberbaumJ. P.KoseS.JohnsonM. R.AranaG. W.SullivanL. K.HamnerM. B.… GeorgeM. S. (2004). Neural correlates of speech anticipatory anxiety in generalized social phobia. Neuroreport, 15, 2701–2705.
95.
LudwigV.MihovY.SchwartingR. K. W. (2008). Behavioral and neurochemical consequences of multiple MDMA administrations in the rat: Role of individual differences in anxiety-related behavior. Behavioural Brain Research, 189, 52–64.
96.
LuiS.HuangX.ChenL.TangH.ZhangT.LiX.… GongQ. (2009). High-field MRI reveals an acute impact on brain function in survivors of the magnitude 8.0 earthquake in China. Proceedings of the National Academy of Sciences of the United States of America, 106, 15412–15417.
97.
MarksI. M. (1987). Fears, phobias, and rituals: Panic, anxiety, and their disorders. New York, NY: Oxford University Press.
98.
MarksI. M.NesseR. M. (1994). Fear and fitness: An evolutionary analysis of anxiety disorders. Ethology and Sociobiology, 15, 147–161.
99.
MathewS. J.HoS. (2006). Etiology and neurobiology of social anxiety disorder. Journal of Clinical Psychiatry, 67, Suppl. 12, 9–13.
100.
McKinneyW. T.Jr.BunneyW. E.Jr. (1969). Animal models of depression: I. Review of evidence: Implications for research. Archives of General Psychiatry, 21, 240–248.
101.
McNaughtonN.CorrP. J. (2004). A two-dimensional neuropsychology of defense: Fear/anxiety and defensive distance. Neuroscience & Biobehavioral Reviews, 28, 285–305.
102.
MehtaP. H.GoslingS. D. (2008). Bridging human and animal research: A comparative approach to studies of personality and health. Brain, Behavior, and Immunity, 22, 651–661.
103.
MillanM. J. (2003). The neurobiology and control of anxious states. Progress in Neurobiology, 70, 83–244.
104.
MolewijkH. E.van der PoelA. M.OlivierB. (1995). The ambivalent behaviour “stretched approach posture” as a paradigm to characterize anxiolytic drugs. Psychopharmacology, 121, 81–90.
105.
MontgomeryK. C. (1955). The relation between fear induced by novel stimulation and exploratory behaviour. The Journal of Comparative and Physiological Psychology, 48, 254–260.
106.
MorrisP. H.GaleA.DuffyK. (2002). Can judges agree on the personality of horses?Personality and Individual Differences, 33, 67–81.
107.
MottaV.MaisonnetteS.MoratoS.CastrechiniP.BrandãoM. L. (1992). Effects of blockade of 5-HT2 receptors and activation of 5-HT1A receptors on the exploratory activity of rats in the elevated plus-maze. Psychopharmacology, 107, 135–139.
108.
NoblettK. L.CoccaroE. F. (2005). Molecular genetics of personality. Current Psychiatry Reports, 7, 73–80.
109.
Nunes-de-SouzaR. L.Canto-de-SouzaA.RodgersR. J. (2002). Effects of intra-hippocampal infusion of WAY-100635 on plus-maze behavior in mice. Influence of site of injection and prior test experience. Brain Research, 927, 87–96.
110.
OhlF. (2003). Testing for anxiety. Clinical Neuroscience Research, 3, 233–238.
111.
PankseppJ. (1998). Affective neuroscience: The foundations of human and animal emotions. New York, NY: Oxford University Press.
112.
PawlakC. R.HoY. J.SchwartingR. K. W. (2008). Animal models of human psychopathology based on individual differences in novelty-seeking and anxiety. Neuroscience & Biobehavioral Reviews, 32, 1544–1568.
113.
PawlakC. R.HoY. J.SchwartingR. K. W.BauhoferA. (2003). Relationship between striatal levels of interleukin-2 mRNA and plus-maze behaviour in the rat. Neuroscience Letters, 341, 205–208.
114.
PawlakC. R.SchwartingR. K. W. (2002). Object preference and nicotine consumption in rats with high vs. low rearing activity in a novel open field. Pharmacology, Biochemistry and Behavior, 73, 679–687.
115.
PawlakC. R.SchwartingR. K. W. (2006a). Striatal microinjections of interleukin-2 and rat behaviour in the elevated plus-maze. Behavioural Brain Research, 168, 339–344.
PawlakC. R.SchwartingR. K. W.BauhoferA. (2005). Cytokine mRNA levels in brain and peripheral tissues of the rat: Relationships with plus-maze behavior. Molecular Brain Research, 137, 159–165.
118.
PawlakC. R.WeyersP. (2006). Tiermodelle für Angst und Angststörungen. Ausgewählte Modelle und Ansätze zur Untersuchung individueller Differenzen [Animal models for anxiety and anxiety disorders – Selected models and approaches to study individual differences]. Psychologische Rundschau, 57, 139–153.
119.
PellowS.ChopinP.FileS. E.BrileyM. (1985). Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. Journal of Neuroscience Methods, 14, 149–167.
120.
PereiraJ. K. D.VieiraR. J.KonishiC. T.de RibeiroR. A.Frussa-FilhoA. (1999). The phenomenon of “one-trial tolerance” to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze is abolished by the introduction of a motivational conflict situation. Life Sciences, 65, PL101–107.
121.
PerkinsA. M.EttingerU.DavisR.FosterR.WilliamsS. C. R.CorrP. J. (2009). Effects of Lorazepam and citalopram on human defensive reactions: Ethopharmacological differentiation of fear and anxiety. The Journal of Neuroscience, 29, 12617–12624.
122.
PetittoJ. M.LysleD. T.GariepyJ.LewisM. H. (1994). Association of genetic differences in social behavior and cellular immune responsiveness: Effects of social experience. Brain, Behavior, and Immunity, 8, 111–123.
123.
PetittoJ. M.LysleD. T.GariepyJ.ClubbP. H.CairnsR. L.LewisM. H. (1993). Genetic differences in social behavior: Relation to natural killer cell function and susceptibility to tumor development. Neuropsychopharmacology, 8, 35–43.
124.
PhelpsE. A.LeDouxJ. E. (2005). Contributions of the amygdala to emotion processing: From animal models to human behavior. Neuron, 48, 175–187.
125.
PinelJ. P. J.ManaM. J. (1989). Adaptive interactions of rats with dangerous inanimate objects: Support for a cognitive theory of defensive behavior. In BlanchardR. J.BrainP. F.ParmigianiS.BlanchardD. C. (Eds.), Ethoexperimental approaches to the study of behavior (pp. 137–150). Dordrecht, The Netherlands: Kluwer Academic Publishers.
126.
PinelJ. P. J.TreitD. (1978). Burying as a defensive response in rats. The Journal of Comparative and Physiological Psychology, 92, 708–712.
127.
RaisonC. L.CapuronL.MillerA. H. (2006). Cytokines sing the blues: Inflammation and the pathogenesis of depression. Trends in Immunology, 27, 24–31.
128.
ReimanE. M.RaichleM. E.RobinsE.MintunM. A.FusselmanM. J.FoxP. T.… HackmanK. A. (1989). Neuroanatomical correlates of a lactate-induced anxiety attack. Archives of General Psychiatry, 46, 493–500.
129.
ReynoldsS. M.BerridgeK. C. (2002). Positive and negative motivation in nucleus accumbens shell: Bivalent rostrocaudal gradients for GABA-elicited eating, taste “liking”/“disliking” reactions, place preference/avoidance, and fear. The Journal of Neuroscience, 22, 7308–7320.
130.
RichardI. H.SchifferR. B.KurlanR. (1996). Anxiety and Parkinson’s disease. The Journal of Neuropsychiatry and Clinical Neurosciences, 8, 383–392.
131.
RichelleM. (1968). The integration of behavior as a variable in psychopharmacological research. Journal of Physiology (Paris), 60, Suppl. 1, 149–203.
132.
RodgersR. J. (1997). Animal models of “anxiety”: Where next?Behavioural Pharmacology, 8, 477–496.
133.
RodgersR. J.CaoB. J.DalviA.HolmesA. (1997). Animal models of anxiety: An ethological perspective. Brazilian Journal of Medical and Biological Research, 30, 289–304.
134.
RodgersR. J.ColeJ. C. (1993). Influence of social isolation, gender, strain and prior novelty on plus-maze behaviour in mice. Physiology & Behavior, 54, 729–736.
135.
RodgersR. J.LeeC.ShepherdJ. K. (1992). Effects of diazepam on behavioural and antinociceptive responses to the elevated plus-maze in male mice depend upon treatment regimen and prior maze experience. Psychopharmacology, 106, 102–110.
136.
RodgersR. J.ShepherdJ. K. (1993). Influence of prior maze experience on behaviour and response to diazepam in the elevated plus-maze and light/dark tests of anxiety in mice. Psychopharmacology, 113, 237–242.
137.
RoganM. T.LeonK. S.PerezD. L.KandelE. R. (2005). Distinct neural signatures for safety and danger in the amygdala and striatum of the mouse. Neuron, 46, 309–320.
138.
SantucciL. B.DaudM. M.AlmeidaS. S.de OliveiraL. M. (1994). Effects of early protein malnutrition and environmental stimulation upon the reactivity to diazepam in two animal models of anxiety. Pharmacology, Biochemistry and Behavior, 49, 393–398.
139.
SapolskyR. M.RayJ. C. (1989). Styles of dominance and their endocrine correlates among wild olive baboons (Pabio anubis). American Journal of Primatology, 18, 1–13.
140.
SareenJ.CampbellD. W.LeslieW. D.MaliszaK. L.SteinM. B.PaulusM. P.… ReissJ. P. (2007). Striatal function in generalized social phobia: A functional magnetic resonance imaging study. Biological Psychiatry, 61, 396–404.
141.
SchenbergE. E.FerreiraT. L.FigueredoL. Z. P.HipólideD. C.NobregaJ. N.OliveiraM. G. M. (2006). Fear conditioning performance and NMDA receptor subtypes: NR2A differential expression in the striatum. Brain Research Bulletin, 69, 440–446.
142.
SchillerD.LevyI.NivY.Le DouxJ. E.PhelpsE. A. (2008). From fear to safety and back: Reversal of fear in the human brain. The Journal of Neuroscience, 28, 11517–11525.
143.
SchneiderP.HoY.-J.SpanagelR.PawlakC. R. (2011). A novel elevated plus-maze procedure to avoid the one-trial tolerance problem. Frontiers in Behavioral Neuroscience, 5, 43, doi: 10.3389/fnbeh.2011.0004310.3389/fnbeh.2011.00043
144.
SchneiderP.SpanagelR.PawlakC. R. (2009). Interleukin-2 affects social interaction behaviour in relation to anxiety-like trait behaviour in the elevated plus-maze in adult Wistar rats. Brain, Behavior, and Immunity, 23, Suppl. 1, S19.
SchoenbaumG.SetlowB. (2003). Lesions of nucleus accumbens disrupt learning about aversive outcomes. The Journal of Neuroscience, 23, 9833–9841.
147.
SchwabeK.KleinS.KochM. (2006). Behavioural effects of neonatal lesions of the medial prefrontal cortex and subchronic pubertal treatment with phencyclidine of adult rats. Behavioural Brain Research, 168, 150–160.
148.
SchwartingR. K. W.PawlakC. R. (2004). Behavioral neuroscience in the rat: Taking the individual into account. Methods and Findings in Experimental and Clinical Pharmacology, 26, Suppl. 2, 17–22.
149.
SchwartingR. K. W.ThielC. M.MüllerC. P.HustonJ. P. (1998). Relationship between anxiety and serotonin in the ventral striatum. Neuroreport, 9, 1025–1029.
150.
SilvaR. C. B.BrandãoM. L. (2000). Acute and chronic effects of gepirone and fluoxetine in rats tested in the elevated plus-maze: An ethological analysis. Pharmacology, Biochemistry and Behavior, 65, 209–216.
151.
SmeetsW. J. A. J.MarínO.GonzálezA. (2000). Evolution of the basal ganglia: New perspectives through a comparative approach. Journal of Anatomy, 196, 501–517.
152.
SteimerT.DriscollP. (2003). Divergent stress responses and coping styles in psychogenetically selected Roman high-(RLA) and low-(RLA) avoidance rats: Behavioural, neuroendocrine and developmental aspects. Stress, 6, 87–100.
153.
SteimerT.DriscollP. (2005). Inter-individual vs line/strain differences in psychogenetically selected Roman high-(RHA) and low-(RLA) avoidance rats: Neuroendocrine and behavioural aspects. Neuroscience & Biobehavioral Reviews, 29, 99–112.
154.
SteinD. J.StahlS. (2000). Serotonin and anxiety: Current models. International Clinical Psychopharmacology, 15, Suppl. 2, S1–S6.
155.
StrackF.DeutschR. (2004). Reflective and impulsive determinants of social behavior. Personality and Social Psychology Review, 8, 220–247.
156.
StrelauJ. (1997). The contribution of Pavlov’s typology of CNS properties to personality research. European Psychologist, 2, 125–138.
157.
TellegenA.WallerN. G. (1992). Exploring personality through test construction: Development of the multidimensional personality questionnaire. Unpublished manuscript, University of Minnesota Press.
158.
ThielC. M.MüllerC. P.HustonJ. P.SchwartingR. K. W. (1999). High versus low reactivity to a novel environment: Behavioural, pharmacological and neurochemical assessments. Neuroscience, 93, 243–251.
159.
TollefsonG. D.RosenbaumJ. F. (1998). Selective serotonin reuptake inhibitors. In SchatzbergA. F.NemeroffC. B. (Eds.), Textbook of psychopharmacology (pp. 219–237). Washington, DC: American Psychiatric Press.
160.
TreitD. (1985). Animal models for the study of anti-anxiety agents: A review. Neuroscience and Biobehavioral Reviews, 9, 203–222.
161.
TreitD.MenardJ.RoyanC. (1993). Anxiogenic stimuli in the elevated plus-maze. Pharmacology, Biochemistry and Behavior, 44, 463–469.
162.
UenoK. I.TogashiH.MoriK.MatsumotoM.OhashiS.HoshinoA.… YoshiokaM. (2002). Behavioural and pharmacological relevance of stroke-prone spontaneously hypertensive rats as an animal model of a developmental disorder. Behavioural Pharmacology, 13, 1–13.
163.
van den HeuvelO. A.VeltmanD. J.GroenewegenH. J.CathD. C.van BalkomA. J. L. M.van HartskampJ.van DyckR. (2005a). Frontal-striatal dysfunction during planning in obsessive-compulsive disorder. Archives of General Psychiatry, 62, 301–310.
164.
van den HeuvelO. A.VeltmanD. J.GroenewegenH. J.WitterM. P.MerkelbachJ.CathD. C.van DyckR. (2005b). Disorder-specific neuroanatomical correlates of attentional bias in obsessive-compulsive disorder, panic disorder, and hypochondriasis. Archives of General Psychiatry, 62, 922–933.
165.
VyasA.ChattarjiS. (2004). Modulation of different states of anxiety-like behavior by chronic stress. Behavioral Neuroscience, 118, 1450–1454.
166.
WahlstenD.MettenP.PhillipsT. J.BoehmS. L.IIBurkhart-KaschS.DorowJ.… CrabbeJ. C. (2003). Different data from different labs: Lessons from studies of gene–environment interaction. Journal of Neurobiology, 54, 283–311.
167.
WalfA. A.FryeC. A. (2007). The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nature Protocols, 2, 322–328.
168.
WeintraubD.NewbergA. B.CaryM. S.SiderowfA. D.MobergP. J.Kleiner-FismanG.… KatzI. R. (2005). Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson’s disease. The Journal of Nuclear Medicine, 46, 227–232.
169.
WeissS. M.WadsworthG.FletcherA.DourishC. T. (1998). Utility of ethological analysis to overcome locomotor confounds in elevated maze models of anxiety. Neuroscience & Biobehavioral Reviews, 23, 265–271.
170.
WichersM.MaesM. (2002). The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans. International Journal of Neuropsychopharmacology, 5, 375–388.
171.
WiggerA.SánchezM. M.MathysK. C.EbnerK.FrankE.LiuD.… LandgrafR. (2004). Alterations in central neuropeptide expression, release, and receptor binding in rats bred for high anxiety: Critical role of vasopressin. Neuropsychopharmacology, 29, 1–14.
172.
WillnerP. (1984). The validity of animal models of depression. Psychopharmacology, 83, 1–16.
173.
WillnerP. (1986). Validation criteria for animal models of human mental disorders: Learned helplessness as a paradigm case. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 10, 677–690.
174.
WillnerP. (1991). Behavioural models in psychopharmacology. In WillnerP. (Ed.), Behavioural models in psychopharmacology: Theoretical, industrial and clinical perspectives (pp. 3–18). Cambridge, UK: Cambridge University Press.
175.
WillnerP.MitchellP. J. (2002). Animal models of depression: A diathesis/stress approach. In D’HaenenH.den BoerJ. A.WillnerP. (Eds.), Biological psychiatry (pp. 703–726). Chichester, UK: Wiley.
176.
WoodcockJ. (2007). The prospects for “personalized medicine” in drug development and drug therapy. Journal of Clinical Pharmacy and Therapeutics, 81, 164–169.
177.
WuJ. C.BuchsbaumM. S.HersheyT. G.HazlettE.SicotteN.JohnsonJ. C. (1991). PET in generalized anxiety disorder. Biological Psychiatry, 29, 1181–1199.
178.
WuS. L.HsuL. S.TuW. T.WangW. F.HuangY. T.PawlakC. R.HoY. J. (2008). Effects of d-cycloserine on the behavior and ERK activity in the amygdala: Role of individual anxiety levels. Behavioural Brain Research, 187, 246–253.
179.
YehudaR.HymanS. E. (2005). The impact of terrorism on brain, and behavior: What we know and what we need to know. Neuropsychopharmacology, 30, 1773–1780.
180.
YerkesR. M.YerkesA. W. (1936). Nature and conditions of avoidance (fear) responses in chimpanzees. Journal of Comparative Psychology, 21, 53–66.
